Ling Wei

1.8k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Ling Wei is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ling Wei has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Ling Wei's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (7 papers). Ling Wei is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (7 papers). Ling Wei collaborates with scholars based in China, United States and Romania. Ling Wei's co-authors include Ming Yang, Nasha Zhang, Xingwu Wang, Liyan Lv, Yan Zheng, Jujie Sun, Jiandong Liu, Yue Shen, Yeyang Xu and Yemei Song and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ling Wei

42 papers receiving 1.2k citations

Hit Papers

Noncoding RNAs in gastric cancer: implications for drug r... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Noncoding RNAs in gastric cancer: implications for drug resistance
    2020 351 citations Ling Wei, Nasha Zhang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Wei China 15 853 738 143 113 101 43 1.2k
Jun Deng China 24 995 1.2× 743 1.0× 176 1.2× 226 2.0× 67 0.7× 75 1.4k
Xuan Su China 16 469 0.5× 240 0.3× 114 0.8× 119 1.1× 40 0.4× 57 799
Xiaofeng Lai China 13 594 0.7× 347 0.5× 102 0.7× 129 1.1× 64 0.6× 21 878
Chian‐Feng Chen Taiwan 18 533 0.6× 240 0.3× 87 0.6× 150 1.3× 63 0.6× 32 830
Zhesheng Wen China 19 606 0.7× 288 0.4× 181 1.3× 295 2.6× 70 0.7× 56 1.0k
Matthieu Meryet‐Figuière France 16 660 0.8× 553 0.7× 48 0.3× 81 0.7× 36 0.4× 30 868
Marisa Shiina United States 21 640 0.8× 444 0.6× 124 0.9× 209 1.8× 26 0.3× 34 926
Amine Belaïd France 13 510 0.6× 243 0.3× 91 0.6× 68 0.6× 295 2.9× 22 821

Countries citing papers authored by Ling Wei

Since Specialization
Citations

This map shows the geographic impact of Ling Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wei more than expected).

Fields of papers citing papers by Ling Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wei. The network helps show where Ling Wei may publish in the future.

Co-authorship network of co-authors of Ling Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Wei. A scholar is included among the top collaborators of Ling Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Wei. Ling Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinpei, Qing Li, Zhen Zhai, et al.. (2025). Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. Cell Reports. 44(8). 116132–116132. 2 indexed citations
2.
Yang, Z. W., Xin Cai, Zhuochen Li, et al.. (2025). CellKAN: Cellular multi-attention Kolmogorov-Arnold networks for nuclei segmentation in histopathology images. Displays. 91. 103246–103246.
3.
Wei, Ling, Leisheng Shi, Ning Wu, et al.. (2025). CircleBase V2: an eccDNA annotation platform across cancers and species. Nucleic Acids Research. 54(D1). D66–D77. 1 indexed citations
4.
Wu, Ning, Ling Wei, Qiang Liu, et al.. (2023). Innovative insights into extrachromosomal circular DNAs in gynecologic tumors and reproduction. Protein & Cell. 15(1). 6–20. 13 indexed citations
5.
Wang, Yanghua, et al.. (2023). A New Generation Cost Analysis Method of High Renewable Penetration Power Grid. 41. 1660–1665. 1 indexed citations
6.
Gao, Yu, Chenchen Feng, Yuexin Zhang, et al.. (2022). TRmir: A Comprehensive Resource for Human Transcriptional Regulatory Information of MiRNAs. Frontiers in Genetics. 13. 808950–808950. 4 indexed citations
7.
Su, Xiaojie, et al.. (2021). Construction and Analysis of the Dysregulated ceRNA Network and Identification of Risk Long Noncoding RNAs in Breast Cancer. Frontiers in Genetics. 12. 664393–664393. 10 indexed citations
8.
He, Yi, et al.. (2020). LncRNA PLAC2 Positively Regulates CDK2 to Promote Ovarian Carcinoma Cell Proliferation. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Wei, Ling, Qiuying Liu, Yuan Huang, et al.. (2020). Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 120. 105685–105685. 11 indexed citations
10.
Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer. 18(1). 147–147. 246 indexed citations
11.
Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cellular Oncology. 42(6). 757–768. 72 indexed citations
12.
Huang, Yuan, Ling Wei, Rongce Zhao, et al.. (2018). Predicting hepatocellular carcinoma development for cirrhosis patients via methylation detection of heparocarcinogenesis-related genes.. Journal of Cancer. 9(12). 2203–2210. 11 indexed citations
13.
Wei, Ling, et al.. (2018). Dual Energy Spectral CT Imaging in the assessment of Gastric Cancer and cell proliferation: A Preliminary Study. Scientific Reports. 8(1). 17619–17619. 26 indexed citations
14.
Wei, Ling, Yuan Huang, Rongce Zhao, et al.. (2017). Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases. Clinical and Experimental Medicine. 18(1). 79–87. 30 indexed citations
15.
Yu, Xiaoqin, Qiuying Liu, Yuan Huang, et al.. (2017). Vigilin interacts with CTCF and is involved in the maintenance of imprinting of IGF2 through a novel RNA–mediated mechanism. International Journal of Biological Macromolecules. 108. 515–522. 9 indexed citations
16.
Wei, Ling, Pengyun Qiao, Ying Shi, et al.. (2016). Triclosan/triclocarban levels in maternal and umbilical blood samples and their association with fetal malformation. Clinica Chimica Acta. 466. 133–137. 78 indexed citations
17.
Yin, Jie, Ling Wei, Ying Shi, et al.. (2015). Chinese population exposure to triclosan and triclocarban as measured via human urine and nails. Environmental Geochemistry and Health. 38(5). 1125–1135. 75 indexed citations
18.
Huang, Wen-Qing, Tong Li, Wenli Yang, et al.. (2015). Analysis of DNA Methylation in Plasma for Monitoring Hepatocarcinogenesis. Genetic Testing and Molecular Biomarkers. 19(6). 295–302. 25 indexed citations
19.
Wei, Ling, Wen Huang, Ran Li, et al.. (2014). Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth. Oncology Reports. 31(5). 2328–2334. 24 indexed citations
20.
Li, Jimei, Zhongyang Lu, Wenlei Li, Shan Yu, & Ling Wei. (2008). Cell death and proliferation in NF-κB p50 knockout mouse after cerebral ischemia. Brain Research. 1230. 281–289. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Deng Breakdown of academic impact, for papers by Xuan Su Breakdown of academic impact, for papers by Xiaofeng Lai Breakdown of academic impact, for papers by Chian‐Feng Chen Breakdown of academic impact, for papers by Zhesheng Wen Breakdown of academic impact, for papers by Matthieu Meryet‐Figuière Breakdown of academic impact, for papers by Marisa Shiina Breakdown of academic impact, for papers by Amine Belaïd
Rankless by CCL
2026